X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (73) 73
hygiene (73) 73
medical or veterinary science (73) 73
preparations for medical, dental, or toilet purposes (73) 73
chemistry (33) 33
metallurgy (33) 33
specific therapeutic activity of chemical compounds ormedicinal preparations (32) 32
beer (31) 31
biochemistry (31) 31
enzymology (31) 31
microbiology (31) 31
mutation or genetic engineering (31) 31
spirits (31) 31
vinegar (31) 31
wine (31) 31
compositions thereof (26) 26
culture media (26) 26
microorganisms or enzymes (26) 26
propagating, preserving or maintaining microorganisms (26) 26
humans (25) 25
oncology (16) 16
female (14) 14
male (14) 14
middle aged (13) 13
physics (13) 13
adult (11) 11
index medicus (11) 11
aged (10) 10
antibodies, monoclonal - therapeutic use (9) 9
investigating or analysing materials by determining theirchemical or physical properties (8) 8
measuring (8) 8
rituximab (8) 8
testing (8) 8
treatment outcome (8) 8
hematology (7) 7
antibodies, monoclonal - adverse effects (6) 6
antibodies, monoclonal, murine-derived (6) 6
antineoplastic agents - therapeutic use (6) 6
aged, 80 and over (5) 5
apparatus for enzymology or microbiology (5) 5
chemotherapy (5) 5
clinical trials as topic (5) 5
advertising (4) 4
antineoplastic agents - adverse effects (4) 4
b-cell lymphoma (4) 4
cancer (4) 4
clinical trials (4) 4
combined modality therapy (4) 4
cryptography (4) 4
display (4) 4
displaying (4) 4
education (4) 4
hematologic neoplasms - therapy (4) 4
labels or name-plates (4) 4
lymphoma, non-hodgkin - drug therapy (4) 4
radioimmunotherapy - methods (4) 4
seals (4) 4
signs (4) 4
acute myelogenous leukemia (3) 3
alk (3) 3
animals (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
article (3) 3
benzamides - therapeutic use (3) 3
cell lung-cancer (3) 3
dosimetry (3) 3
drug resistance, neoplasm (3) 3
drug-resistance (3) 3
entrectinib (3) 3
ibritumomab tiuxetan (3) 3
immunotoxins - therapeutic use (3) 3
indazoles - therapeutic use (3) 3
lymphoma, b-cell - drug therapy (3) 3
lymphoma, non-hodgkin - therapy (3) 3
mice (3) 3
neoplasms (3) 3
p-glycoprotein (3) 3
research (3) 3
southwest-oncology-group (3) 3
toxicity (3) 3
trial (3) 3
acute myeloid leukemia (2) 2
acyclic or carbocyclic compounds (2) 2
adults (2) 2
anaplastic lymphoma kinase (2) 2
anti-cd20 antibody (2) 2
antibodies (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - immunology (2) 2
antibodies, monoclonal - toxicity (2) 2
antineoplastic agents - administration & dosage (2) 2
atp-binding cassette, sub-family b, member 1 - antagonists & inhibitors (2) 2
b cells (2) 2
bone marrow transplantation (2) 2
brief communication (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
cd20 (2) 2
chop chemotherapy (2) 2
chronic lymphocytic-leukemia (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 521 - 521
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 2574 - 2574
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1092 - 1092
Abstract 16,16 dimethyl prostaglandin E2 (FT1050) was previously identified to be a critical regulator of hematopoetic stem cell (HSC) homeostasis and we... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 619 - 619
Journal Article
Cancer Discovery, ISSN 2159-8274, 03/2019, Volume 9, Issue 3, pp. 384 - 395
: fusions are oncogenic drivers of various tumors, including non-small cell lung cancers (NSCLC). The safety and antitumor activity of the multikinase RET... 
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 12/2015, Volume 14, Issue 12 Supplement 2, pp. C188 - C188
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2003, Volume 348, Issue 26, pp. 2691 - 2694
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2003, Volume 348, Issue 26, pp. 2690 - 2691
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14_Supplement, pp. CT007 - CT007
Background: Entrectinib is a potent oral inhibitor of the tyrosine kinases TrkA, TrkB, TrkC (encoded by the genes NTRK1, NTRK2, NTRK3, respectively), ROS1, and... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3807 - 3807
Abstract Umbilical cord blood (UCB) offers many potential advantages as a source of hematopoietic stem cells (HSCs) for allogeneic transplantation, including... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.